Cyclopofol + Propofol
ApprovedUNKNOWN 0 views this week 0 watching💤 Quiet
Interest: 39/100
39
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Postoperative Delirium
Conditions
Postoperative Delirium, Stroke
Trial Timeline
Oct 1, 2023 → Dec 31, 2024
NCT ID
NCT06046638About Cyclopofol + Propofol
Cyclopofol + Propofol is a approved stage product being developed by Haisco Pharmaceutical Group for Postoperative Delirium. The current trial status is unknown. This product is registered under clinical trial identifier NCT06046638. Target conditions include Postoperative Delirium, Stroke.
What happened to similar drugs?
10 of 20 similar drugs in Postoperative Delirium were approved
Approved (10) Terminated (1) Active (10)
Hype Score Breakdown
Clinical
20
Activity
4
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT06046638 | Approved | UNKNOWN |
Competing Products
20 competing products in Postoperative Delirium